The instant test that lets you diagnose your illness
New disruptive technology developed by Israeli startup Azure PCR could make diagnosis of illness – whether it’s viral, bacterial or even fungal – instant.
New disruptive technology developed by Israeli startup Azure PCR could make diagnosis of illness – whether it’s viral, bacterial or even fungal – instant.
Jerusalem-based Aerodentis offers a high-tech alternative to clunky orthodontic braces, and you only wear it while you’re sleeping.
ISRAEL21c compiles a list of the 10 most extraordinary medical devices and pharmaceuticals that promise to revolutionize global healthcare.
‘We must learn how to leverage our culture of entrepreneurship in high-tech and look 10 years ahead to cope with competition,’ says chief scientist at business confab.
In an upcoming space mission, the Vecoy platform – which tricks viruses into committing suicide – will be tested to see how it works in zero gravity.
Once-a-month treatment for multiple sclerosis, and painkiller Tapentadol, gain US patents – inching Israeli pharma company closer to the market.
‘This conference — this magnitude and scale — I have never seen anything like it in the world,’ says participant from Brown University.
A unique new glue, inspired by algae, was developed to meet a need in vascular surgery but could be used for any operation.
Israel’s scientists are behind a range of innovations that dramatically improve eyesight or quality of life for people with vision impairments.
Two-thirds of the world population is infected with H. pylori bacteria. An Israeli company offers the most advanced diagnostic system to find it.
Biodesign Innovation Program benefits from the expertise of Jerusalem’s best and brightest in medicine, business, engineering and law.
BoneCure, a revolutionary artificial membrane that speeds and simplifies bone re-growth in pets, may also be headed for the human market.
The Israeli company’s special therapeutic contact lenses offer a novel way to treat painful corneal edema.
Israel’s annual International Biotechnology Conference (BioMed) attracts interest from one of Italy’s largest labs, among other foreign companies.
Merger to produce new medications for sufferers of growth hormone deficiency, hemophilia, obesity and diabetes.